Test Price
2,800 AED✅ Home Collection Available
EOMES Gene Neuronal Migration Disorder Genetic Test in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% diagnostic sensitivity via ISO 9001:2015 accredited processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
- Clinical Guidance: Telephonic post-test clinical guidance in result interpretation.
- Insurance: Direct billing verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The EOMES gene NGS test screens for pathogenic variants linked to neuronal migration disorders, enabling precise diagnosis and personalized management. This next-generation sequencing identifies mutations in the EOMES gene that can cause microcephaly, polymicrogyria, and related neurodevelopmental conditions.
| Feature | Our Test (EOMES NGS) | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Precision | 100% coverage, high-depth NGS | Limited to single amplicon, lower sensitivity |
| Method | Next Generation Sequencing (Illumina) | Sanger sequencing |
| Speed | 3–4 Weeks | 4–6 Weeks |
Physician Insight & Safety Protocols
"The EOMES gene plays a critical role in neuronal migration during cortical development. Identifying pathogenic variants through high-depth NGS allows clinicians to confirm a diagnosis of microcephaly or polymicrogyria, tailor surveillance protocols, and provide informed genetic counselling to families. A negative result does not exclude all genetic etiologies, and findings must always be correlated with neuroimaging and clinical presentation."
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Medication Advisory
Do not discontinue any prescribed medication without consulting your treating physician. Genetic testing is a diagnostic aid and is not a substitute for ongoing medical management or emergency care.
Exclusion Criteria & ER Red Flags
- Exclusion Criteria: Patients with hemodynamic instability, severe coagulopathy, or inability to provide informed consent are not eligible for home phlebotomy.
- ER Red Flags: Sudden onset of seizures, loss of consciousness, severe headache, or focal neurological deficits demand immediate emergency care — do not wait for genetic results.
- Important: This test does not replace urgent neuroimaging or acute clinical assessment. Always follow DHA emergency management protocols.
Patient FAQ & Clinical Guidance
1. What is the purpose of this EOMES genetic test?
A: This test identifies disease-causing mutations in the EOMES gene to confirm a diagnosis of neuronal migration disorder and guide treatment. Mutations in EOMES are associated with primary microcephaly, polymicrogyria, and other brain malformations; confirming a variant helps tailor therapy and surveillance.
2. How is the test performed and what sample is required?
A: A trained phlebotomist collects a small blood sample or a drop on an FTA card, which is then processed using high-sensitivity NGS. Whole blood, extracted DNA, or a dry blood spot on an FTA card are all acceptable; our temperature-controlled cold-chain logistics ensure sample stability from your doorstep to the laboratory.
3. Are there any risks or limitations I should know about?
A: This NGS-based genetic test has a diagnostic sensitivity exceeding 99.9% for coding variants, but may not detect deep-intronic or large structural rearrangements. A negative result does not exclude a clinical diagnosis, and incidental findings are handled according to ACMG guidelines. There is no risk beyond routine venipuncture.
UAE Regulatory & Data Privacy Adherence
- Full adherence to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
- All home collections are performed by licensed phlebotomists under DHA-approved facility license No. 1143.
- Laboratory operations certified to ISO 9001:2015 (Certificate INT/EGQ/2509DA/3139).
- Genetic counselling is mandated prior to testing to draw a pedigree chart and inform about possible outcomes.
Clinical & Logistical Metadata
| Test Name | EOMES Gene Neuronal Migration Disorder Sequencing |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Whole Blood, Extracted DNA, or FTA Card Spot |
| Methodology Used | Next-Generation Sequencing (NGS) on Illumina Platform |
| ICD-10-CM Code | Q04.8 |
| LOINC Code | 21636-6 |
| DHA Facility License & Laboratory Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians